Literature DB >> 6511707

Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.

P M Hawkey, C A Hawkey.   

Abstract

The in-vitro susceptibilities of 198 isolates of precisely identified Proteeae species to six quinolone antimicrobials were determined. Significant differences in susceptibility patterns among various Proteeae to the quinolones examined were demonstrated. Although Providencia stuartii was found to be the most resistant to quinolones including the very active agent ciprofloxacin, fully speciated Prov. rettgeri were also markedly resistant as well. in contrast Prov. alcalifaciens was extremely sensitive to these agents. Some strains of Proteus penneri were more resistant to the three newer compounds (ciprofloxacin, enoxacin and norfloxacin) than strains of Pr. vulgaris suggesting that recognition of this species may be important in surveys of the in-vitro activity of antibiotics. Pr. mirabilis and Morganella morganii were very sensitive to the newer agents. The patterns of resistance seen in the three newer agents were reflected in the older agents acrosoxacin and cinoxacin. Accurate speciation of Proteeae in surveys of susceptibilities to antimicrobial agents is important if misleading results are not to be reported.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511707     DOI: 10.1093/jac/14.5.485

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

Review 2.  [Enoxacin: spectrum and activity of its antibacterial effect].

Authors:  A Bauernfeind; H Flamm; H Grimm; H Hahn; F Kayser; W Opferkuch; J Potel; R Malottke; H G Sonntag; W H Traub
Journal:  Infection       Date:  1986       Impact factor: 3.553

3.  Analysis of antibiotic resistance determinants in Proteus penneri.

Authors:  S Lukomski; M Pytlos; L Serwecinska; Z Sidorczyk; A Jaworski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

Review 4.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 5.  Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

6.  In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.

Authors:  G Cornaglia; R Pompei; B Dainelli; G Satta
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 7.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.